| Literature DB >> 29398678 |
Si-Li Zheng1, Zhi-Yong Li1, Zheng Zhang2, Dong-Sheng Wang1, Jian Xu3, Chao-Yu Miao1.
Abstract
Metrnl is a newly discovered secreted protein with neurotrophic activity and metabolic effect, while in earlier studies its circulating level in human was not explored. We evaluated two commercial enzyme-linked immunosorbent assay kits (DY7867-05, R&D Systems and SK00478-02, Aviscera Bioscience) for the detection of human circulating Metrnl. The DY7867-05 kit showed superiority over the SK00478-02 kit since it generated better curve fitting degree, smaller variation among tests, higher inter-assay reproducibility and better specificity, and could effectively detect human Metrnl in six types of blood samples. Subsequent analysis was performed using the DY7867-05 kit. Sample storage conditions were investigated. No gender difference in circulating Metrnl levels was found, while people with newly diagnosed type 2 diabetes mellitus (T2DM) had significantly lower Metrnl levels compared to the healthy controls.Entities:
Keywords: blood sample type; circulating Metrnl; enzyme-linked immunosorbent assay (ELISA); gender difference; sample storage; type 2 diabetes mellitus (T2DM)
Mesh:
Substances:
Year: 2018 PMID: 29398678 DOI: 10.1248/cpb.c17-00846
Source DB: PubMed Journal: Chem Pharm Bull (Tokyo) ISSN: 0009-2363 Impact factor: 1.645